Erick Gamelin

Chief Development Officer

Chief Development Officer at Acrivon Therapeutics, Inc., filing insider transactions on 2026-08-18.

Total Purchases

—

0 transactions

Total Sales

$804

1 transaction

Companies Traded

1 total filings

Active Since

2026-08-18

Last: 2026-08-18

Companies

Acrivon Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-18	ACRV	Sale	400	$2.01	$804	52.6K	SEC ↗